APA (7th ed.) Citation

MM, K., M, H., W, J. P., R, B., H, B., & T, C. (2026). Systematic Benchmarking of CRISPR-Cas9 Off-Target Prediction Tools Reveals Limitations and Implications for Preclinical Assessment. Human gene therapy, 10430342261466407. https://doi.org/10.1177/10430342261466407

Chicago Style (17th ed.) Citation

MM, Kaufmann, Hackenberg M, Jobson Pargeter W, Backofen R, Binder H, and Cathomen T. "Systematic Benchmarking of CRISPR-Cas9 Off-Target Prediction Tools Reveals Limitations and Implications for Preclinical Assessment." Human Gene Therapy 2026: 10430342261466407. https://doi.org/10.1177/10430342261466407.

MLA (9th ed.) Citation

MM, Kaufmann, et al. "Systematic Benchmarking of CRISPR-Cas9 Off-Target Prediction Tools Reveals Limitations and Implications for Preclinical Assessment." Human Gene Therapy, 2026, p. 10430342261466407, https://doi.org/10.1177/10430342261466407.